摘要
目的:探讨高血压病患者血浆CRP浓度水平及洛汀新降压前后的变化。方法:分别测定高血压病组和正常对照组CRP的浓度水平,洛汀新口服12周后两组的血浆CRP浓度变化。结果:高血压患者组血浆CRP浓度水平与正常对照组比较有显著差异,高血压3级与高血压2级血浆CRP浓度水平有显著差异,与1级无显著差异,洛汀新在控制血压同时,亦降低血浆CRP浓度水平。结论:洛汀新在控制血压,同时能降低血浆CRP浓度。
Objective： To investigate the plasma CRP levels before and after treatment with lotensin in patients with essential hypertension. Method： Determination of essential hypertension group and normal control group the concentration of CRP level lotensin oral group after 12 weeks of the change in plasma CRP concentration. Result： The plasma CRP in patients with high blood pressure levels compared with normal control group were significantly different, plasma CRP levels high blood pressure 3 and high blood pressure 3 were significantly different, There＇s no significant differences in blood pressure in the control Lotensin also reduced the plasma CRP levels. Conclusion： Lotensin in controlling blood pressure, at the same time to reduce the concentration of plasma CRP.
出处
《河北医学》
CAS
2009年第8期901-903,共3页
Hebei Medicine
关键词
高血压病
洛汀新
C反应蛋白
Hypertension
Lotensin
C - reactive protein
